Work

Prevalence and characterization of dermatologic adverse events related to alpelisib (BYL719) in breast cancer patients.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.1063

Authors: Dulce M. Barrios M.S, Diana G. Wang, Victoria Susana Blinder, Jacqueline Bromberg, Pamela Drullinsky, Samuel Aaron Funt, Komal L. Jhaveri, Diana Lake, Tomas Lyons, Shanu Modi, Pedram Razavi, Michelle Sidel, Tiffany A. Traina, Linda T. Vahdat, Mario E. Lacouture

Institutions: Memorial Sloan Kettering Cancer Center, Novartis (United States)

Language: English

Topic: Chemotherapy-related skin toxicity

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W3031303092

Cites:

Cited by: 3

Related to: 10